Literature DB >> 12931643

[Botulinum toxin injection into the cricopharyngeal muscle for dysphagia: report of 2 successful cases].

Tomokazu Yokoyama1, Masao Asai, Masanobu Kumada, Shinji Usui, Takeo Kobayasi.   

Abstract

Dysphagia is frequently observed in patients with sequelae after multiple cerebral infarctions and those with neuromyopathy. Dysphagia in these patients can be successfully treated by laryngeal suspension and cricopharyngeal myotomy. Surgery is not indicated in senile patients with serious complications, where conservative treatment is performed. We injected botulinum toxin into the right cricopharyngeal muscle with excellent results in two dysphagic patients with multiple cerebral infarction who refused surgery. There two cases developed dysphasia after multiple cerebral infarction, where surgical therapy was not indicated. Dysphagia is successfully treated by 5 units of botulinum toxin injected into the cricopharyngeal muscle. Botulinum toxin injection is considered useful for dysphagia in patients in whom surgery is not indicated. The effect of botulinum toxin lasts for 3 to 4 months. Injection of botulinum toxin is useful for patients with temporary dysphasia after cerebral infarction and soon improves swallowing with the assistance of rehabilitation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12931643     DOI: 10.3950/jibiinkoka.106.754

Source DB:  PubMed          Journal:  Nihon Jibiinkoka Gakkai Kaiho        ISSN: 0030-6622


  2 in total

Review 1.  Botulinum toxin for gastrointestinal disorders: therapy and mechanisms.

Authors:  H Vittal; P F Pasricha
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

2.  Dysphagia.

Authors:  Dawn D. F. Ferguson; Kenneth R. DeVault
Journal:  Curr Treat Options Gastroenterol       Date:  2004-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.